Chapter 496: Chapter 496

After Faye Sterling returned to the Faulkner Family, she felt things were still not secure enough.

She thought about Eleanor Sterling attending the pharmaceutical conference and a cold smile appeared on her face.

If that distinguished young lady knew that Eleanor was also going to attend the conference and that Mrs. Faulkner had given her the latest drug developed at The Faulkner Labs.

What would she do then?

I heard that the top leader of the International Medical Alliance is Giselle Keating’s brother, and I’m afraid Eleanor might be disqualified then, right?

Faye Sterling picked up her bag, called Giselle Keating, and told her this matter.

In a café, the two sat in a booth.

"Miss Keating, I want to tell you something, Eleanor Sterling is also going to attend the pharmaceutical conference, and she’ll be releasing a new drug,"

Giselle Keating stirred the coffee in front of her, frowning as she listened to Faye.

"She’s not a pharmacist, where did she get a drug to release?"

Faye Sterling smiled faintly, "That’s because Mrs. Faulkner gave it to her, it’s a drug researched by The Faulkner Labs.

Even Mrs. Faulkner is on her side now. I think she might soon ascend to the position of Mrs. Faulkner."

Giselle Keating gritted her teeth, "Impossible! I absolutely won’t let her succeed."

Faye Sterling succeeded in instigating, her smile growing brighter.

"Thank you for telling me this, in The Medical Alliance I will do my best to help you."

After speaking, Giselle Keating got up and left. ᴛʜɪs ᴄʜᴀᴘᴛᴇʀ ɪs ᴜᴘᴅᴀᴛᴇ ʙʏ N0v3l.Fiɾe.net

Watching her departure, Faye Sterling’s expression was mocking; this young lady probably didn’t know she had become a pawn in her game.

After separating from Faye Sterling, Giselle Keating immediately ordered an investigation into The Faulkner Labs’ pharmacists’ information.

As a pharmacist herself, she knew how painful it was for years of research results to be misused.

So she wanted to overthrow Eleanor Sterling, and the key was in this pharmacist.

Soon, the list and contact details of all pharmacists were delivered to her; she contacted the main person in charge and arranged to meet him at a restaurant.

The head in charge of The Faulkner Labs is named Donovan Young, he looked at Giselle Keating and asked, "Miss Keating, what can I do for you?"

Giselle Keating lowered her gaze, hiding the calculating intention in her eyes, and kindly asked, "I heard that your lab developed the latest drug before the pharmaceutical conference?"

Donovan Young was stunned, then nodded, "Yes, we spent two years developing a new type of drug."

Giselle Keating smiled and said, "But your drug was taken by Mrs. Faulkner and attributed to a stranger."

"How could that be?" Donovan Young exclaimed.

Their lab had been working for the Faulkner Group for years, and any drugs developed were to be published but with personal attribution rights.

Seeing his reaction, Giselle Keating knew he was probably unaware of this.

"My fifth brother is the International Medical Alliance’s Alliance Hierarch, I can appeal for your grievances."

"But..." Donovan Young hesitated.

He’s merely the lab director, and the drug wasn’t solely developed by him, but rather a young pharmacist named Finley Lloyd within the team who successfully developed it.

But the attribution was taken, and he was still very dissatisfied.

They worked for The Faulkner Group; can’t they meet even this small requirement?

Giselle Keating clasped her hands, looking at Donovan Young with a smile, "Consider it, if you want to appeal, join me at the pharmaceutical conference, and publicly expose that person who misused your drug."

She acted as if she was thinking for Donovan Young, and a trace of conflict flashed across Donovan’s face.

He had merely handed the drug over but knew nothing of its destination.

But thinking of their hard work day and night, even the naming right was taken away, then this hardship was in vain.

He must seek justice for Finley Lloyd!

Donovan Young didn’t hesitate long; he nodded and agreed, "Alright, I’ll go to the pharmaceutical conference with you."